The Research Observatory of the Institute of Catalan Studies (OR-IEC) published in his blog a report analyzing data from biomedical research projects granted by the Instituto de Salud Carlos III (ISCIII) in recent years. The data suggest that Catalonia has a great capacity to raise funds within Spain, and that the IDIBAPS plays a major role in this capacity.
Archive for the ‘Hospital Clínic’ Category
The Neuroimmunology Program is dedicated to medical care and research on inflammatory diseases of the brain, such as multiple sclerosis, autoimmune encephalitis and optical neuromyelitis. It is an initiative led by researchers from the Hospital Clínic of Barcelona and the IDIBAPS, which combines basic research with first-class healthcare in a unique translational research team. On May 29, coinciding with the International Day of Multiple Sclerosis, the Neuroimmunology Program coordinators have presented to the scientific community the challenges and research objectives that they face from the newly created CELLEX Biomedical Research Center of IDIBAPS. Dr. Harmut Wekerle, a leader in neuroimmunology from the Max-Planck Institute (Germany), participated in the presentation event.
Findings from the Alcohol Public Health Research Alliance (AMPHORA) project will be presented in the European Parliament on May 15th, as part of the ‘Awareness Week on Alcohol Related Harm’. The project leaders will call on the European representatives for an integrated approach to the European alcohol problem, including obligatory warning labels, banning advertising and closing the treatment gap for those with alcohol problems. The project involved over 30 institutions from 13 european countries, and was coordinated from Hospital Clínic of Barcelona by Dr. Antoni Gual, director of the Addictions Unit at Hospital Clínic and investigator at IDIBAPS.
Europe organizes in May the European Month of the Brain. IDIBAPS organizes its research devoted to the study of this complex organ through the Clinical and Experimental Neuroscience Area. This Institute is an international benchmark in many areas of research in neuroscience, a leading role reflected in the variety of activities planned during May. The proposals range from educational activities to first class scientific meetings or a presentation at the European Parliament of the findings reached by a research project coordinated from IDIBAPS – Hospital Clínic of Barcelona.
The Director of the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Dr. Ramon Gomis, has been awarded with the Creu de Sant Jordi 2013, together with 24 other personalities and 25 institutions. The Creu de Sant Jordi 2013 is the recognition that the Government of Catalonia awards to individuals and institutions for their outstanding services to Catalonia in politics, society or culture. Dr. Gomis is an endocrinologist with a long career at the Hospital Clínic of Barcelona, professor at the University of Barcelona and influent scientist in diabetes, combined with a solid career as a writer.
Bipolar disorder is a serious psychiatric condition very common, affecting about 2 or 3% of the general population. This disease also affects in sick leaves hospitalization and social problems. Many patients also present suicidal behavior. Patients who do not take drug treatments have high autolytic risk. It is estimated that the risk of death by suicide, particularly in unmedicated patients reaches 15%. Suicide is a very complex behavior which is believed that, like other psychiatric diseases, there are many small effect genes interact with each other and also interact with other types of environmental factors, psychological or psychosocial.
Researchers Bipolar Disorders Program of the IDIBAPS – Hospital Clínic, leded by Dr. Eduard Vieta, have published a study in the journal European Neuropsychopharmacology, which shows that there are genetic aspects determining suicidality of bipolar patients. Results approach suicide concept to a biological basis, bringing it closer to the disease. Dr. Antoni Benabarre is the principal investigator and the IDIBAPS predoctoral fellow, Esther Jimenez, the first signer. Read the rest of this entry »